Farmers Trust Co. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,899 shares of the company’s stock after selling 76 shares during the quarter. Procter & Gamble accounts for approximately 1.2% of Farmers Trust Co.’s holdings, making the stock its 26th biggest position. Farmers Trust Co.’s holdings in Procter & Gamble were worth $6,186,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of PG. Concurrent Investment Advisors LLC increased its stake in shares of Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Copley Financial Group Inc. purchased a new position in Procter & Gamble in the third quarter valued at about $668,000. Fortem Financial Group LLC acquired a new position in Procter & Gamble in the 4th quarter worth about $569,000. Synovus Financial Corp raised its stake in shares of Procter & Gamble by 3.4% during the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after purchasing an additional 6,077 shares in the last quarter. Finally, Nordea Investment Management AB lifted its holdings in shares of Procter & Gamble by 7.5% during the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock valued at $484,583,000 after buying an additional 201,695 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
NYSE PG traded up $0.78 on Wednesday, reaching $162.08. The company’s stock had a trading volume of 2,823,317 shares, compared to its average volume of 6,081,301. The firm has a market cap of $381.71 billion, a PE ratio of 27.94, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The business has a 50-day moving average price of $169.92 and a 200 day moving average price of $169.75.
Wall Street Analysts Forecast Growth
Several research firms have commented on PG. JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Piper Sandler assumed coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. DA Davidson reissued a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Friday, December 27th. Finally, Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a research note on Monday, September 30th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $179.75.
Read Our Latest Report on Procter & Gamble
Insider Buying and Selling
In related news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock worth $13,317,460 in the last quarter. Insiders own 0.18% of the company’s stock.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Manufacturing Stocks Investing
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- ETF Screener: Uses and Step-by-Step Guide
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Investing In Preferred Stock vs. Common Stock
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.